Sonja Nelson
Director of Finance/CFO chez AMBRX INC
Fortune : 147 $ au 31/03/2024
Profil
Sonja Nelson is currently an Independent Director at Motus GI Holdings, Inc. and the Chief Financial Officer at Ambrx, Inc. She also holds the position of Chief Financial Officer at Ambrx Biopharma Cayman, Inc. and Ambrx Biopharma, Inc. Ms. Nelson previously worked as the Director-General Accounting at Cricket Communications, Inc. from 2008 to 2012.
She then served as the Senior Director & Controller at Mallinckrodt Hospital Products, Inc. from 2012 to 2014.
From 2017 to 2021, Ms. Nelson was a Director at Inex Bio, Inc. She also held the role of Chief Financial Officer at NantKwest, Inc. from 2018 to 2021.
Additionally, she worked as the Vice President & Controller at AltheaDx, Inc. from 2014 to 2015.
Ms. Nelson has an undergraduate degree from Agnes Scott College and the University of Pforzheim.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOTUS GI HOLDINGS, INC.
0,01% | 05/03/2024 | 335 ( 0,01% ) | 147 $ | 31/03/2024 |
Postes actifs de Sonja Nelson
| Sociétés | Poste | Début |
|---|---|---|
| MOTUS GI HOLDINGS, INC. | Director/Board Member | 22/06/2021 |
| AMBRX INC | Director of Finance/CFO | 01/06/2021 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director of Finance/CFO | 30/06/2021 |
Anciens postes connus de Sonja Nelson
| Sociétés | Poste | Fin |
|---|---|---|
Inex Bio, Inc.
 Inex Bio, Inc. Financial ConglomeratesFinance Part of ImmunityBio, Inc., Inex Bio, Inc. is a South Korean company that provides investment services. The private company is located in South Korea. Inex Bio was acquired by NantKwest, Inc. from Inexbio Holdings LLC on March 30, 2015 for $37.85 million. | Director/Board Member | 01/06/2021 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/06/2021 |
| IMMUNITYBIO, INC. | Director of Finance/CFO | 09/03/2021 |
| ALTHEADX INC | Comptroller/Controller/Auditor | 01/10/2015 |
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 01/06/2014 |
Formation de Sonja Nelson
| Agnes Scott College | Undergraduate Degree |
| University of Pforzheim | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MOTUS GI HOLDINGS, INC. | Health Technology |
| IMMUNITYBIO, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cricket Communications, Inc.
 Cricket Communications, Inc. Wireless TelecommunicationsCommunications Cricket Communications, Inc. provided mobile wireless services. It use to offer popular games, ring tones, wallpapers and international long distance and roaming services. The company was founded in 1999 and was headquartered in San Diego, CA. | Communications |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
AltheaDx, Inc.
 AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
NEON Enterprise Software LLC
 NEON Enterprise Software LLC Information Technology ServicesTechnology Services NEON Enterprise Software, Inc. develops software and data management solutions for compliance, data retention, IMS and DB2 tools. It offers Eclipse iRepair tool for viewing, analyzing and repairing IMS database data sets. The company was founded by John J. Moores in 1995 and is headquartered in Sugar Land, TX. | Technology Services |
Inex Bio, Inc.
Inex Bio, Inc. Financial ConglomeratesFinance Part of ImmunityBio, Inc., Inex Bio, Inc. is a South Korean company that provides investment services. The private company is located in South Korea. Inex Bio was acquired by NantKwest, Inc. from Inexbio Holdings LLC on March 30, 2015 for $37.85 million. | Finance |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
